Bill to pay for multi-cancer early detection screening test has bipartisan support, but just ran out of time last session.

Discover why Exact Sciences, a leading oncology diagnostics company, may see growth in the cancer diagnostics market with its ...

Repositioning to better reach the elusive 45- to 50-year-old segment of potential colon cancer screening patients, Cologuard ads have replaced people singing a version of the Sinatra standard ...

It developed Cologuard, a screening test for the early detection of colorectal cancer and pre-cancer. The company was founded on February 10, 1995 and is headquartered in Madison, WI.

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, will present 11 abstracts ...

One of the 30-second spots taps into the intensity of hit shows like “Game of Thrones.” It starts with a medieval royal preparing to go to war in the name of colorectal cancer screening, declaring, ...

For every birdie made on the 15th hole, the Cologuard Classic by Exact Sciences will donate $1,500 to pay for a cancer ...

TUCSON, Ariz. (KVOA) - The Cologuard Classic will tee off from La Paloma Country Club in just over a month. The tournament brings world-class golf to Tucson, but it's so much more than that.

2025 plans include launching Cologuard Plus, Oncodetect, and Cancerguard cancer tests. For 2024, the company expects screening revenue of $2.104 billion, up 13%, and Precision Oncology revenue of ...

In addition, new modeling data from the validated CRC-AIM model shows that screening with triennial Cologuard (mt-sDNA) at published adherence rates results in fewer CRC cases, lower treatment ...